Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile

mSphere (Oct 2021)

Affiliations

N. Jan: ORCiD; Department of Medicine, Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA
R. A. Hays: Department of Medicine, Gastroenterology & Hepatology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
D. N. Oakland: Department of Medicine, Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA
P. Kumar: Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA
G. Ramakrishnan: Department of Medicine, Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA
B. W. Behm: Department of Medicine, Gastroenterology & Hepatology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
W. A. Petri: ORCiD; Department of Medicine, Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA
C. Marie: ORCiD; Department of Medicine, Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA

Abstract

Fecal microbiota transplantation (FMT) is an effective treatment for C. difficile